Takeda Pharmaceutical (TAK) |
Japan |
$63.340B |
10.01 |
Zoetis (ZTS) |
United States |
$59.218B |
35.42 |
Astellas Pharma (ALPMY) |
Japan |
$32.299B |
16.13 |
Eisai (ESALY) |
Japan |
$21.220B |
40.92 |
Grifols, S.A (GRFS) |
Spain |
$15.628B |
20.48 |
UCB SA (UCBJF) |
Belgium |
$15.483B |
0.00 |
Merck (MKGAF) |
Germany |
$14.519B |
19.81 |
Neurocrine Biosciences (NBIX) |
United States |
$10.262B |
484.48 |
Ono Pharmaceutical (OPHLF) |
Japan |
$9.450B |
20.20 |
Ionis Pharmaceuticals (IONS) |
United States |
$8.752B |
17.73 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$8.480B |
10.83 |
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) |
Italy |
$8.449B |
0.00 |
Catalent (CTLT) |
United States |
$7.643B |
31.09 |
IPSEN SA ADR (IPSEY) |
France |
$7.310B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$6.443B |
97.57 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$6.226B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$5.849B |
30.12 |
STADA ARZNEIMI (STDAF) |
Germany |
$5.375B |
0.00 |
Hypermarcas (HYPMY) |
Brazil |
$5.026B |
18.07 |
FibroGen (FGEN) |
United States |
$4.157B |
122.15 |
United Therapeutics (UTHR) |
United States |
$4.114B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$3.833B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$3.761B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$3.591B |
13.13 |
Evotec AG (EVTCY) |
Germany |
$3.498B |
57.24 |
PTC Therapeutics (PTCT) |
United States |
$2.941B |
0.00 |
ArQule (ARQL) |
United States |
$2.413B |
0.00 |
Heron Therapeutics (HRTX) |
United States |
$2.302B |
0.00 |
Zogenix (ZGNX) |
United States |
$2.136B |
0.00 |
Xencor (XNCR) |
United States |
$2.127B |
64.65 |
Portola Pharmaceuticals (PTLA) |
United States |
$2.093B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.979B |
63.10 |
ChemoCentryx (CCXI) |
United States |
$1.932B |
0.00 |
Tilray (TLRY) |
Canada |
$1.903B |
0.00 |
Pacira Pharmaceuticals (PCRX) |
United States |
$1.899B |
56.19 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.721B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$1.654B |
17.64 |
Corcept Therapeutics (CORT) |
United States |
$1.527B |
18.56 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.507B |
10.29 |
Enanta Pharmaceuticals (ENTA) |
United States |
$1.295B |
29.58 |
CLINIGEN GP (CLIGF) |
United Kingdom |
$1.245B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.196B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$1.068B |
0.00 |
Endo (ENDP) |
Ireland |
$1.066B |
1.96 |
Radius Health (RDUS) |
United States |
$1.034B |
0.00 |
Aerie Pharmaceuticals (AERI) |
United States |
$1.024B |
0.00 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$0.983B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.795B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.755B |
0.00 |
Dermira (DERM) |
United States |
$0.702B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.694B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.643B |
0.00 |
ImmunoGen (IMGN) |
United States |
$0.542B |
0.00 |
Translate Bio (TBIO) |
United States |
$0.535B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.529B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.470B |
0.00 |
Organogenesis Holdings (ORGO) |
United States |
$0.445B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.445B |
54.00 |
BioSpecifics Technologies Corp (BSTC) |
United States |
$0.440B |
18.98 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$0.439B |
0.00 |
Aptorum Group (APM) |
Hong Kong, SAR China |
$0.436B |
0.00 |
Harpoon Therapeutics (HARP) |
United States |
$0.435B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.413B |
0.00 |
Indivior (INVVY) |
United States |
$0.412B |
1.49 |
OptiNose (OPTN) |
United States |
$0.393B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.381B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.379B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.375B |
0.00 |
DURECT (DRRX) |
United States |
$0.371B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.369B |
4.30 |
Siga Technologies (SIGA) |
United States |
$0.369B |
8.43 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.329B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.312B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.306B |
4.09 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.301B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.272B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.267B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.257B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.243B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.238B |
0.00 |
Concordia (CXRXF) |
Canada |
$0.215B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.210B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$0.195B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.186B |
32.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.184B |
0.00 |
Foamix Pharmaceuticals (FOMX) |
Israel |
$0.178B |
0.00 |
Taiwan Liposome (TLC) |
Taiwan |
$0.175B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.168B |
0.00 |
IMV INC (IMV) |
Canada |
$0.149B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.145B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.144B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.135B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.129B |
0.00 |
CV Sciences (CVSI) |
United States |
$0.129B |
0.00 |
CannTrust Holdings (CTST) |
Canada |
$0.119B |
0.00 |
ALLERGY THERAPT (AGYTF) |
United Kingdom |
$0.108B |
0.00 |
ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.099B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.092B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.089B |
0.00 |
Capnia (SLNO) |
United States |
$0.085B |
0.00 |
MediWound (MDWD) |
Israel |
$0.082B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.080B |
23.91 |
Oasmia Pharmaceutical AB (OASMY) |
Sweden |
$0.079B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.078B |
0.00 |
Otonomy (OTIC) |
United States |
$0.076B |
0.00 |
Neos Therapeutics (NEOS) |
United States |
$0.074B |
0.00 |
PolarityTE (PTE) |
United States |
$0.073B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.072B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.069B |
0.00 |
Nivalis Therapeutics (ALPN) |
United States |
$0.068B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.066B |
0.00 |
Pharmaxis (PXSLY) |
Australia |
$0.065B |
0.00 |
RENEURON GP (RNUGF) |
United Kingdom |
$0.062B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.058B |
14.55 |
Genocea Biosciences (GNCA) |
United States |
$0.058B |
0.00 |
Novan (NOVN) |
United States |
$0.058B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.055B |
0.00 |
Forward Pharma (FWP) |
Denmark |
$0.055B |
0.00 |
Medicure (MCUJF) |
Canada |
$0.055B |
0.00 |
Mast Therapeutics (SVRA) |
United States |
$0.054B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.051B |
0.00 |
Summit Therapeutics (SMMT) |
United Kingdom |
$0.051B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.048B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.047B |
0.00 |
IsoRay (ISR) |
United States |
$0.044B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.043B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.040B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.040B |
0.00 |
Mannatechorporated (MTEX) |
United States |
$0.038B |
0.00 |
Opexa Therapeutics (ACER) |
United States |
$0.038B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.032B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.030B |
0.00 |
Shineco (TYHT) |
China |
$0.028B |
0.00 |
PharmAthene (ALT) |
United States |
$0.027B |
0.00 |
India Globalization Capital (IGC) |
United States |
$0.027B |
0.00 |
Biomerica (BMRA) |
United States |
$0.026B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.025B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.024B |
0.00 |
Melinta Therapeutics (MLNT) |
United States |
$0.022B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.022B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.022B |
0.00 |
Cardiome Pharma (CORV) |
Canada |
$0.020B |
0.00 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.016B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.016B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.015B |
0.00 |
Flex Pharma (SLRX) |
United States |
$0.015B |
0.00 |
Kitov Pharmaceuticals Holdings (KTOV) |
Israel |
$0.014B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.014B |
0.00 |
Vical (BBI) |
United States |
$0.013B |
0.00 |
Lipocine (LPCN) |
United States |
$0.009B |
0.00 |
Cytori Therapeutics Inc (PSTV) |
United States |
$0.008B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.008B |
0.00 |
Tetraphase Pharmaceuticals (TTPH) |
United States |
$0.007B |
0.00 |
Achieve Life Sciences (ACHV) |
United States |
$0.006B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.006B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.005B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.005B |
0.00 |
Can-Fite Biopharma (CANF) |
Israel |
$0.005B |
0.00 |
Hemispherx BioPharma (AIM) |
United States |
$0.004B |
0.00 |
Midatech Pharma (MTP) |
United Kingdom |
$0.002B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.002B |
0.00 |
Advanced Accelerator Applications S.A (AAAP) |
France |
$0.000B |
0.00 |